Ellie Leick

Articles

Building On Immunotherapy, Preventing Acquired Resistance Are Next Steps in Lung Cancer Research

March 20th 2020

David P. Carbone, MD, PhD, discusses advances in immunotherapy and targeted therapy in non–small cell lung cancer and ongoing research efforts focused on acquired resistance to available therapies.

Proton Therapy Offers More Precision in Lung Cancer, But Lacks Accessibility

March 20th 2020

Terence T. Sio, MD, MS, discusses the utility of proton therapy in lung cancer.

Improvements Needed for Adjuvant Therapy in RCC

March 18th 2020

Che-Kai Tsao, MD, discusses the current unmet needs in adjuvant therapy for patients with renal cell carcinoma and how current research is addressing such challenges.

Treatments for Oncogenic-Driven Lung Cancer Continue to Expand

March 18th 2020

Anastasios Dimou, MD, discusses available and emerging treatment options and approaches for patients with oncogenic-driven lung cancer.

NY-ESO-1, MAGE-A4 Among Key Targets in Sarcoma Research

March 17th 2020

Neeta Somaiah, MD, discusses ongoing research in the field of sarcoma.

Key Advances in Sarcoma Lead to More Personalized Medicine Efforts

March 17th 2020

Jonathan C. Trent, MD, PhD, discusses recent advances and ongoing research in the field of soft tissue sarcoma.

Multidisciplinary Approach Required for Pulmonary Hypertension in Myelofibrosis

March 16th 2020

Juan C. Lopez-Mattei, MD, FACC, FASE, FSCCT, FSCMR, discusses the findings of the retrospective analysis of pulmonary hypertension in patients with myelofibrosis and their impact on clinical practice.

Grivas Shares Insight on Biomarker Research, Combo Strategies in Prostate Cancer

March 11th 2020

Petros Grivas MD, PhD, discusses biomarker-driven and combination research in metastatic castration-resistant prostate cancer.

Early-Stage Pancreatic Cancer Paradigm Needs Refining

March 10th 2020

Matthew H.G. Katz, MD, FACS, discusses data with neoadjuvant therapy and ongoing research in pancreatic cancer.

BiTEs and CAR T Cells Burst Through ALL Paradigm

March 9th 2020

Mohammad Maher Abdul-Hay, MD, discusses current standards for the treatment of patients with acute lymphocytic leukemia.

Research With BCMA-Targeted Agents, Venetoclax Appears Promising in Myeloma

March 9th 2020

Gareth J. Morgan, MD, PhD, discusses ongoing research of BCMA-targeted therapies, as well as the use of venetoclax in the myeloma treatment paradigm.

Research With BCMA-Targeted Agents, Venetoclax Appears Promising in Myeloma

March 7th 2020

Gareth J. Morgan, MD, PhD, discusses ongoing research of BCMA-targeted therapies, as well as the use of venetoclax in the myeloma treatment paradigm.

Triplets Target Lenalidomide-Refractory Myeloma Subgroup

March 5th 2020

Faith E. Davies, MD, discusses pivotal research in relapsed/refractory myeloma and precision medicine efforts in the field.

Follicular Lymphoma Moves Toward Chemo-Free Regimens

March 4th 2020

Michael L. Grossbard, MD, discusses recent changes to the follicular lymphoma paradigm and therapeutic approaches on the horizon.

MPN Research Efforts Expand Beyond JAK1/2 Inhibition, Transplant

March 4th 2020

Shella Saint Fleur-Lominy, MD, PhD, discusses some of the current and investigational treatment options for patients with myeloproliferative neoplasms.

Biomarker-Driven NSCLC Paradigm Advances With Novel Agents, Liquid Biopsies

March 4th 2020

Jonathan W. Goldman, MD, discusses the current landscape of biomarker-driven lung cancer.

Novel Combos Thrive in Myeloma, But Challenges Remain

March 3rd 2020

James Weitzman, MD, discusses progress in the multiple myeloma treatment paradigm and what challenges remain.

Pivotal Data Demonstrate Importance of Lung Cancer Screening

March 3rd 2020

Michael K. Gould, MD, MS, discusses pivotal lung cancer screening trials and their impact on clinical practice.

More Research Required to Determine Best Practices in High-Risk Myeloma

February 27th 2020

Andrew Branagan, MD, discusses the evolving role of transplant and ongoing research in high-risk multiple myeloma.

Modern Surgical and Staging Techniques Coming to Forefront of Endometrial Cancer

February 27th 2020

Ian S. Hagemann, MD, PhD, discusses identifying resectable lymph nodes via ultrastaging and the importance of multidisciplinary treatment in patients with endometrial cancer.